Company Filing History:
Years Active: 2006
Title: Innovator Spotlight: Jean-Frédéric Colombel
Introduction: Jean-Frédéric Colombel, based in La Madeleine, France, is a notable inventor with a keen focus on pharmaceutical innovations. He has made significant contributions to the field, notably through his invention of synthetic oligomannosides.
Latest Patents: Colombel holds a patent for "Synthetic oligomannosides, preparation and uses thereof." This patent describes a pharmaceutical composition that comprises a therapeutically effective amount of at least one oligomannoside produced by chemical synthesis. These oligomannosides are homologous to wall oligomannosides of infectious organisms or pathogens, or derivatives thereof, in combination with a pharmaceutically acceptable vehicle.
Career Highlights: Jean-Frédéric Colombel is associated with the Centre Hospitalier Regional Universitaire, where he has dedicated his expertise to medical research and pharmaceutical development. His work in creating effective therapeutic compositions has paved the way for advancements in treating infections.
Collaborations: Throughout his career, Colombel has collaborated with distinguished colleagues, including Jacques Esnault and Pierre Sinay. These partnerships have fostered an environment of innovation and have contributed to the successful development of his research and patents.
Conclusion: Jean-Frédéric Colombel's contributions, particularly in the realm of synthetic oligomannosides, exemplify the critical role inventors play in advancing medical sciences. His work not only enhances our understanding of therapeutic compositions but also serves as a foundation for future developments in pharmaceuticals.